MEI Pharma, Inc. (NASDAQ:MEIP) Receives Average Recommendation of “Hold” from Analysts
Shares of MEI Pharma, Inc. (NASDAQ:MEIP – Get Free Report) have been given an average rating of “Hold” by the six research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has issued a buy recommendation […]
More Stories
Lennar (NYSE:LEN) Price Target Cut to $205.00 by Analysts at UBS Group
Lennar (NYSE:LEN – Free Report) had its price objective trimmed by UBS Group from $225.00 to $205.00 in a report...
Sparta Capital (CVE:SAY) Stock Price Down 25% – Time to Sell?
Sparta Capital Ltd. (CVE:SAY – Get Free Report)’s share price traded down 25% during trading on Thursday . The company...
MTB Metals (CVE:MTB) Trading Down 33.3% – Here’s What Happened
MTB Metals Corp. (CVE:MTB – Get Free Report) shares fell 33.3% during trading on Thursday . The stock traded as...
MTB Metals (CVE:MTB) Stock Price Down 33.3% – Here’s What Happened
Shares of MTB Metals Corp. (CVE:MTB – Get Free Report) were down 33.3% during trading on Thursday . The stock...
MTB Metals (CVE:MTB) Shares Down 33.3% – Here’s Why
MTB Metals Corp. (CVE:MTB – Get Free Report) shares dropped 33.3% during mid-day trading on Thursday . The stock traded...
Carnival Co. & (NYSE:CUK) Issues Q1 2025 Earnings Guidance
Carnival Co. & (NYSE:CUK – Get Free Report) issued an update on its first quarter 2025 earnings guidance on Friday...